首页|期刊导航|中国药理学通报|肿瘤相关巨噬细胞自噬在肺癌中的作用机制及其在耐药中的作用研究进展

肿瘤相关巨噬细胞自噬在肺癌中的作用机制及其在耐药中的作用研究进展OA

Research progress on mechanism of tumor-associated macrophage autophagy in lung cancer and its role in drug resistance

中文摘要英文摘要

肺癌是全球发病率和死亡率最高的恶性肿瘤之一,尽管靶向治疗和免疫治疗已取得进展,但多数患者仍面临耐药、转移和复发等难题.肿瘤相关巨噬细胞(tumor-associated macrophages,TAMs)是肺癌及多种实体瘤微环境中具有高度可塑性的先天免疫细胞,参与肿瘤发生、免疫耐药及治疗应答过程.在肺癌治疗中,自噬的激活或抑制对调控肿瘤细胞死亡起着决定性作用,且与肿瘤微环境密切相关.因此,揭示TAMs与肿瘤细胞间自噬的调控机制,期望取得突破性进展,为抗肿瘤免疫机制研究开辟新方向,同时提高癌症免疫治疗的疗效.该文还剖析了当前研究的局限性,并对未来研究方向进行了展望,以期为肺癌的治疗提供新思路和理论依据.

Lung cancer is one of the most prevalent and lethal malignant tumors worldwide.Although targeted therapy and im-munotherapy have made progress,most patients still face chal-lenges such as drug resistance,metastasis,and recurrence.Tumor-associated macrophages(TAMs)are highly plastic in-nate immune cells in the microenvironment of lung cancer and various solid tumors,involved in tumor development,immune resistance,and treatment response processes.In lung cancer treatment,the activation or inhibition of autophagy plays a deci-sive role in regulating tumor cell death,and is closely related to the tumor microenvironment.Therefore,revealing the regula-tory mechanism of autophagy between TAMs and tumor cells is expected to achieve breakthrough progress,opening up new di-rections for the study of anti-tumor immune mechanisms,and improving the efficacy of cancer immunotherapy.This article also analyzes the current limitations of research and looks for-ward to future research directions,with the aim of providing new ideas and theoretical basis for the treatment of lung cancer.

张媛媛;梁建庆;李金田;张文慧;杨璇

甘肃中医药大学中医临床学院甘肃中医药大学基础医学院,甘肃 兰州 730000甘肃中医药大学中医临床学院甘肃中医药大学基础医学院,甘肃 兰州 730000甘肃中医药大学基础医学院,甘肃 兰州 730000

医药卫生

肺癌肿瘤相关巨噬细胞自噬耐药靶向治疗

lung cancertumor-associated macrophagesau-tophagydrug resistancetargeted therapy

《中国药理学通报》 2026 (8)

1413-1418,6

国家自然科学基金资助项目(No 82560964,82160872)2024年度中医学一级学科"岐黄英才"导师专项基金博导项目(No ZYXKBD-202418)2021年度甘肃省"双一流"科研重点项目

10.12360/CPB202602017

评论